secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axogen, Inc. (AXGN)
CIK:        0000805928
Form:       8-K
Filed at:   2026-11-09T13:52:05+00:00
Accession:  0000805928-26-000110
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Axogen posts Nov 9, 2026 investor deck for prostate nerve reconstruction event; no financials disclosed
--------------------------------------------------------------------------------

- Axogen published a corporate presentation dated November 9, 2026 to ir.axogeninc.com tied to a 'Prostate Nerve Reconstruction Investor Event' held that day.
- Exhibit 99.1 as furnished contains only the deck's title/cover text; no revenue, EPS, guidance, or pipeline data appears in the filing.
- Company states the presentation may be used from time to time in conversations with analysts and investors under Regulation FD.
- No executives, directors, deal terms, or clinical results are named anywhere in the filing or exhibit text.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/805928/000080592826000110/0000805928-26-000110-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/805928/000080592826000110/axgn-20261109.htm
  HTML page:      https://secwatch.observer/filing/0000805928-26-000110

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer